Changes of femoral periprosthetic bone mineral density 6 years after treatment with alendronate following total hip arthroplasty

Journal of Orthopaedic Research

Volumn 27, Issue 2, 2009, Pages 183-188

  Arabmotlagh, Mohammad ^a   Pilz, Mathias ^a   Warzecha, Jörg ^a   Rauschmann, Michael ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Alendronate; Bone remodeling; Bone resorption; DEXA; Hip arthroplasty

Indexed keywords

ALENDRONIC ACID; BONE DENSITY CONSERVATION AGENT;

ARTICLE; BONE DENSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACTIVITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HIP ARTHROPLASTY; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ADULT; AGED; BONE REMODELING; DRUG EFFECT; FEMUR; FOLLOW UP; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PHOTON ABSORPTIOMETRY; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; RADIOGRAPHY;

ABSORPTIOMETRY, PHOTON; ADMINISTRATION, ORAL; ADULT; AGED; ALENDRONATE; ARTHROPLASTY, REPLACEMENT, HIP; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE REMODELING; FEMALE; FEMUR; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OSTEOLYSIS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES;

EID: 59449090632     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20748     Document Type: Article

References (26)

1. Kilgus DJ, Shimaoka EE, Tipton JS, et al. 1993. DEXA measurement of bone mineral density around porous coated cementless femoral implants: methods and preliminary results. J Bone Joint Surg Br 75:279-287.
2. Kiratli BJ, Checovich MM, McBeath AA, et al. 1996. Measurement of bone mineral density by DEXA in patient with the Wisconsin hip, an uncemented femoral stem. J Arthroplasty 11:184-193.
3. Kröger H, Venesmaa P, Jurvelin J, et al. 1998. Bone density at the proximal femur after total hip arthroplasty. Clin Orthop 352:66-74.
4. Trevisan C, Bigoni M, Randelli G, et al. 1997. Periprosthetic bone density around fully hydroaptite coated femoral stem. Clin Orthop 340:109-117.
5. Arabmotlagh M, Hennigs TH, Rittmeister M. 2003. Femoral periprosthetic bone remodeling after implantation of custom made anatomic and standard straight stem hip prosthesis. Z. Orthop. 141:519-525.
6. Brodner W, Bitzan P, Lomoschitz F, et al. 2004. Changes of bone mineral density in the proximal femur after cementless total hip arthroplasty: A five-year longitudinal study. J Bone Joint Surg Br 86:20-26.
7. Petersen MB, Kolthoff N, Eiken P. 1995. Bone mineral density around femoral stems. DEXA measurements in 22 porous coated implants after 5 years. Acta Orthop Scand 66:432-434.
8. Venesmaa PK, Kroger HP, Miettinen HJ, et al. 2001. Monitoring of periprosthetic BMD after uncemented total hip arthrosplasty with dual energy x-ray absorptiometry, a 3 year follow-up study. J Bone Miner Res 16:1056-1061.
9. Espehaug B, Havelin LI, Engesaeter LB, et al. 1997. Patient-related risk factors for early revision of total hip replacement. A. population register-based case-control study of 674 revised hips. Acta Orthop 68:207-215.
10. Furnes O, Lie SA, Espehaug B, et al. 2001. Hip disease and the prognosis of total hip replacement. A. review of 53698 primary total hip replacement reported to the Norwegian arthroplasty register1987-99. J Bone Joint Surg Br 83:579-586.
11. Lewallen DG, Berry DJ. 1998. Periprosthetic fracture of the femur after total hip arthroplasty: treatment and results to date. Instr Course Lect 47:243-249.
12. Karpf DB, Shapiro DR, Seeman E. 1997. Prevention of nonvertebral fractures by alendronate: a meta-analysis. JAMA 277:1159-1164.
13. Libermann UA, Weiss SR, Bröll J, et al. 1995. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N. Engl J Med 333: 1437-1443.
14. Venesmaa PK, Kröger HP, Miettinen HJ, et al. 2001. Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty: a prospective randomized study. J Bone Min Res 16:2126-2131.
15. Wilkinson JM, Stockley I, Peel N, et al. 2001. Effect of Pamidronate in preventing local bone loss after total hip arthroplasty: a randomized double-blind, controlled trial. J Bone Min Res 3:556-564.
16. Yamasaki S, Masuhara K, Yamaguchi K, et al. 2007. Risedronate reduces postoperative bone resorption after cementless total hip arthroplasty. Osteoporos Int 18:1009-1015.
17. Hennigs T, Arabmotlagh M, Schwarz A, et al. 2002. Dose dependent prevention of early periprosthetic bone loss by alendronate. Z. Orthop 140:42-47.
18. Gruen TA, McNeice GM, Amstutz HC. 1979. Modes of failure of cemented stem-type femoral components. Clin Orthop 141:17-27.
19. Shetty N, Hamer A, Stockley I, et al. 2006. Clinical and radiological outcome of total hip replacement five years after pamidronate therapy. J Bone Joint Surg Br 88:1309-1315.
20. Wolff J. 1892. Das Gesetz der Transformation der Knochen. Berlin: Hirschwald.
21. Harris NJ, Lowman A, Wolsey L, et al. 2000. Changes in bone turnover and bone density after total hip arthroplasty. Hip Int 10:16-20.
22. Millett PJ, Alen MJ, Bostrom MP. 2002. Effect of alendronate on particle-induced osteolysis in a rat model. J Bone Joint Surg Am 84-A:236-249.
23. Aspenberg P, Van der Vis H. 1998. Migration, particles and fluid pressure, a discussion of causes of prosthetic loosening. Clin Orthop 352:75-80.
24. Jacobs JJ, Sumner DR, Galante JO. 1993. Mechanism of bone loss associated with total hip replacement. Ortho Clin North Am 24-IV:583-590.
25. Eberhardt C, Habermann B, Müller S, et al. 2007. The bisphosphonate ibandronate accelerates osseointegration of hydroxyapatite-coated cementless implants in an animal model. J Orthop Sci 12:61-66.
26. Black DM, Delmas PD, Eastell R, et al. 2007. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809-1822.